News

Pfizer's stock has taken a tumble, but the story isn’t over—it's just pivoting to the next act. Once flying high on pandemic ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...
UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.
BRUSSELS (Reuters) -Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' ...
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...